يعرض 521 - 540 نتائج من 19,550 نتيجة بحث عن '(( significantly increased decrease ) OR ( significant ((teer decrease) OR (a decrease)) ))*', وقت الاستعلام: 0.51s تنقيح النتائج
  1. 521

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  2. 522

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  3. 523

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  4. 524
  5. 525
  6. 526
  7. 527
  8. 528
  9. 529

    Fig 10 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  10. 530

    Fig 4 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  11. 531

    Fig 9 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  12. 532

    Fig 6 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  13. 533

    Fig 7 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  14. 534

    Fig 8 - حسب Farshid Maleki (20521649)

    منشور في 2025
    الموضوعات:
  15. 535

    A representative ultrasound axis image. حسب Eun-Seon Yang (19751340)

    منشور في 2024
    الموضوعات:
  16. 536
  17. 537
  18. 538
  19. 539
  20. 540